News
ASCO details how to manage ongoing cancer drug shortage
“This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”
News
FDA OKs new agent to block chemotherapy-induced neutropenia
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
News
Surgery is falling out of favor in rectal cancer
“This case series shows that rectal cancer is increasingly being managed medically,” the authors said.
News
Low vitamin D linked to paclitaxel-induced peripheral neuropathy
These results also “suggest that vitamin D supplementation in patients with lower levels of vitamin D may reduce peripheral neuropathy ...”
News
This tool can predict recurrence in rectal cancer watchful waiting
This validation study confirms that the Immunoscore biopsy “is an independent parameter predicting time to recurrence” and can help physicians and...
News
Stripped privileges: An alarming precedent for community oncologists?
The outcome, some community oncologists say, could set a new precedent in how far large health care organizations will go to take their patients...
News
FDA OKs ivosidenib for IDH1-mutated myelodysplastic syndromes
For adults with a rare form of myelodysplastic syndromes, the FDA has approved a targeted therapy called ivosidenib.
News
Does surgery improve survival in metastatic breast cancer?
“The analysis revealed no overall survival benefit for patients who underwent surgical excision of their primary breast tumor.”
News
CT simulation not needed in palliative radiotherapy planning
“Diagnostic CT-based radiation planning substantially reduces time in the [treatment] center without a detriment in plan deliverability or quality...
News
Cost concerns lead to cancer treatment delays, nonadherence
Hospital-based financial navigators may help cancer patients negotiate the intricacies of insurance coverage, experts suggest.
News
FDA approves bosutinib for children with CML
Bosutinib, a tyrosine kinase inhibitor, has been approved by the FDA for treatment of child patients with chronic myelogenous leukemia.
News
Older women who get mammograms risk overdiagnosis
The proportion of older women who continue to receive screening mammograms and may experience breast cancer overdiagnosis is “considerable” and “...
News
FDA approves JAK inhibitor momelotinib for myelofibrosis with anemia
Momelotinib is the fourth JAK inhibitor approved by the FDA to treat the anemia that often accompanies myelofibrosis, a rare form of blood cancer...
News
FDA approves motixafortide for stem cell mobilization in myeloma
Motixafortide has been approved by the FDA to help mobilize hematopoietic stem cells in autologous transplants for patients with multiple myeloma...
News
Delaying palliative chemo may improve QoL without affecting survival for asymptomatic patients
For asymptomatic patients, delaying the start of systemic therapy should be discussed with the patient.